News and Analysis

Lumen Bioscience takes in $16m Series B

Seattle-based Lumen Bioscience, a biopharmaceutical company, has raised $16 million in Series B funding.

-

Seattle-based Lumen Bioscience, a biopharmaceutical company, has raised $16 million in Series B funding. WestRiver Management and Bioeconomy Capital led the round with participation from other investors that included Avista Development and Columbia Pacific.

Source: Press Release